首页 > 最新文献

World Journal of Surgical Oncology最新文献

英文 中文
A rare case report of omental synovial sarcoma complicated hemoperitoneum and literature review. 网膜滑膜肉瘤并发腹腔积血的罕见病例报告和文献综述。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-14 DOI: 10.1186/s12957-024-03559-3
Nguyen Van Manh, Doan Thanh Huy, Vo Thi Tram Anh, Nguyen Huu Thanh, Kelly Marie Smith

Background: Synovial sarcoma is a rare malignant soft tissue tumor originating mainly in the extremities and usually related to the joint capsule, tendon sheath, or synovial capsule. Only a few cases of synovial sarcoma arising in the abdomen, particularly the omentum, have been reported. We presented a case of omental synovial sarcoma and reviewed 7 cases of this disease.

Case presentation: A 37-year-old man presented to the hospital with abdominal pain and distension for 2 months. A computed tomography scan revealed a massive heterogeneous low attenuation mass with amorphous solid components between the stomach and colon with suspected hemoperitoneum. The patient underwent surgery, and the pathological result demonstrated a greater omentum biphasic synovial sarcoma. Chemotherapy was administered with a good response. He has no signs of recurrence during 3 years of follow-up. Among 7 cases of omental synovial sarcoma, the mean age was 42, ranging from 16 to 66 years old with predominantly female (71.4%), tumor size from 9.5 cm to 20 cm. Biphasic synovial sarcoma accounted for 50%. The recurrence rate within one year is high (57.1%).

Conclusions: Primary omental synovial sarcoma is uncommon and presents with nonspecific clinical symptoms, often leading to potential misdiagnosis with other conditions before surgery. They occur predominantly in females, mainly middle-aged, with a large mass size before presentation. Due to the high recurrence and mortality rate, it needs to be recognized at the early stage.

背景:滑膜肉瘤是一种罕见的恶性软组织肿瘤,主要起源于四肢,通常与关节囊、腱鞘或滑膜囊有关。关于腹部(尤其是网膜)发生的滑膜肉瘤,目前仅有少数病例报道。我们报告了一例网膜滑膜肉瘤病例,并回顾了该病的 7 个病例:一名 37 岁男子因腹痛和腹胀 2 个月来院就诊。计算机断层扫描显示,胃和结肠之间有一个巨大的异质低衰减肿块,内含无定形固体成分,疑似血性腹水。患者接受了手术,病理结果显示为大网膜双相滑膜肉瘤。化疗效果良好。随访 3 年未见复发迹象。在 7 例大网膜滑膜肉瘤患者中,平均年龄为 42 岁,从 16 岁到 66 岁不等,以女性为主(71.4%),肿瘤大小从 9.5 厘米到 20 厘米不等。双相滑膜肉瘤占 50%。一年内的复发率很高(57.1%):结论:原发性大网膜滑膜肉瘤并不常见,临床表现为非特异性症状,常常导致手术前被误诊为其他疾病。原发性大网膜滑膜肉瘤并不常见,临床表现为非特异性症状,手术前常被误诊为其他疾病。由于复发率和死亡率较高,因此需要在早期发现。
{"title":"A rare case report of omental synovial sarcoma complicated hemoperitoneum and literature review.","authors":"Nguyen Van Manh, Doan Thanh Huy, Vo Thi Tram Anh, Nguyen Huu Thanh, Kelly Marie Smith","doi":"10.1186/s12957-024-03559-3","DOIUrl":"10.1186/s12957-024-03559-3","url":null,"abstract":"<p><strong>Background: </strong>Synovial sarcoma is a rare malignant soft tissue tumor originating mainly in the extremities and usually related to the joint capsule, tendon sheath, or synovial capsule. Only a few cases of synovial sarcoma arising in the abdomen, particularly the omentum, have been reported. We presented a case of omental synovial sarcoma and reviewed 7 cases of this disease.</p><p><strong>Case presentation: </strong>A 37-year-old man presented to the hospital with abdominal pain and distension for 2 months. A computed tomography scan revealed a massive heterogeneous low attenuation mass with amorphous solid components between the stomach and colon with suspected hemoperitoneum. The patient underwent surgery, and the pathological result demonstrated a greater omentum biphasic synovial sarcoma. Chemotherapy was administered with a good response. He has no signs of recurrence during 3 years of follow-up. Among 7 cases of omental synovial sarcoma, the mean age was 42, ranging from 16 to 66 years old with predominantly female (71.4%), tumor size from 9.5 cm to 20 cm. Biphasic synovial sarcoma accounted for 50%. The recurrence rate within one year is high (57.1%).</p><p><strong>Conclusions: </strong>Primary omental synovial sarcoma is uncommon and presents with nonspecific clinical symptoms, often leading to potential misdiagnosis with other conditions before surgery. They occur predominantly in females, mainly middle-aged, with a large mass size before presentation. Due to the high recurrence and mortality rate, it needs to be recognized at the early stage.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"301"},"PeriodicalIF":2.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic impact of the newly revised IASLC proposed grading system for invasive lung adenocarcinoma: a systematic review and meta-analysis. 新修订的 IASLC 浸润性肺腺癌建议分级系统的预后影响:系统综述和荟萃分析。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-14 DOI: 10.1186/s12957-024-03584-2
Yingding Ruan, Wenjun Cao, Jianwei Han, Aiming Yang, Jincheng Xu, Ting Zhang

Background: This study aimed to evaluate the prognostic value of the newly revised International Association for the Study of Lung Cancer (IASLC) grading system (2020) on the 5-year overall survival (OS) and recurrence-free survival (RFS) in patients with lung adenocarcinoma (LADC).

Methods: Clinical studies that investigated the prognostic value of revised IASLC staging system in patients with LADC were retrieved from the PubMed, Web of Science, ScienceDirect, and Cochrane Library databases. This study was conducted in accordance to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and checklists.

Results: Based on inclusion and exclusion criteria, we included 12 studies for analysis. The grade of LADC was assessed by revised IASLC system, which included three grades. Compared to Grade 3 LADC, grade 1 (total [95% CI]: 1.38 [1.19, 1.60]) and grade 2 (total [95% CI]: 1.29 [1.15, 1.44]) LADC had higher 5-year OS rates. Similarly, Grade 1 (total [95% CI]: 1.76 [1.42, 2.18]) and Grade 2 (total [95% CI]: 1.51 [1.28, 1.77]) had higher 5-year RFS rates Grade 3 LADC. However, 5-year OS and RFS had no significant difference between Grade 1 and Grade 2 patients.

Conclusion: This systematic review and meta-analysis provides evidence that the newly revised IASLC grading system is significantly associated with the prognosis of patients with LADC, where Grade 3 indicated unfavorable prognosis.

研究背景本研究旨在评估新修订的国际肺癌研究协会(IASLC)分级系统(2020年)对肺腺癌(LADC)患者5年总生存期(OS)和无复发生存期(RFS)的预后价值:方法:从PubMed、Web of Science、ScienceDirect和Cochrane Library数据库中检索了研究修订版IASLC分期系统对肺腺癌患者预后价值的临床研究。本研究按照 2020 年系统综述和荟萃分析首选报告项目(PRISMA)指南和核对表进行:根据纳入和排除标准,我们纳入了 12 项研究进行分析。LADC的分级采用修订后的IASLC系统进行评估,包括三个等级。与3级LADC相比,1级(总[95% CI]:1.38 [1.19, 1.60])和2级(总[95% CI]:1.29 [1.15, 1.44])LADC的5年OS率更高。同样,1级(总计[95% CI]:1.76 [1.42,2.18])和2级(总计[95% CI]:1.51 [1.28,1.77])3级LADC的5年RFS率较高。然而,1级和2级患者的5年OS和RFS无明显差异:本系统综述和荟萃分析提供的证据表明,新修订的IASLC分级系统与LADC患者的预后显著相关,其中3级表示预后不良。
{"title":"Prognostic impact of the newly revised IASLC proposed grading system for invasive lung adenocarcinoma: a systematic review and meta-analysis.","authors":"Yingding Ruan, Wenjun Cao, Jianwei Han, Aiming Yang, Jincheng Xu, Ting Zhang","doi":"10.1186/s12957-024-03584-2","DOIUrl":"10.1186/s12957-024-03584-2","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to evaluate the prognostic value of the newly revised International Association for the Study of Lung Cancer (IASLC) grading system (2020) on the 5-year overall survival (OS) and recurrence-free survival (RFS) in patients with lung adenocarcinoma (LADC).</p><p><strong>Methods: </strong>Clinical studies that investigated the prognostic value of revised IASLC staging system in patients with LADC were retrieved from the PubMed, Web of Science, ScienceDirect, and Cochrane Library databases. This study was conducted in accordance to the 2020 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and checklists.</p><p><strong>Results: </strong>Based on inclusion and exclusion criteria, we included 12 studies for analysis. The grade of LADC was assessed by revised IASLC system, which included three grades. Compared to Grade 3 LADC, grade 1 (total [95% CI]: 1.38 [1.19, 1.60]) and grade 2 (total [95% CI]: 1.29 [1.15, 1.44]) LADC had higher 5-year OS rates. Similarly, Grade 1 (total [95% CI]: 1.76 [1.42, 2.18]) and Grade 2 (total [95% CI]: 1.51 [1.28, 1.77]) had higher 5-year RFS rates Grade 3 LADC. However, 5-year OS and RFS had no significant difference between Grade 1 and Grade 2 patients.</p><p><strong>Conclusion: </strong>This systematic review and meta-analysis provides evidence that the newly revised IASLC grading system is significantly associated with the prognosis of patients with LADC, where Grade 3 indicated unfavorable prognosis.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"302"},"PeriodicalIF":2.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An additional gastrojejunostomy may reduce the incidence of moderate and severe delayed gastric emptying after distal segmental duodenectomy for gastrointestinal stromal tumors. 在胃肠道间质瘤远端十二指肠切除术后,附加胃空肠造口术可降低中度和重度胃排空延迟的发生率。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-14 DOI: 10.1186/s12957-024-03585-1
Wei-Wei Jia, Jian-Hui Wu, Cui Yang, Dao-Ning Liu, Xiao-Peng Wang, Rong-Ze Sun, Cheng-Peng Li, Chun-Yi Hao

Background: To investigate whether an additional gastrojejunostomy reduces the incidence of delayed gastric emptying (DGE) following a distal segmental duodenectomy for duodenal and proximal jejunal gastrointestinal stromal tumors (GIST).

Materials and methods: This retrospective review of the GIST database at Peking University Cancer Hospital included 50 patients who underwent distal segmental duodenectomies for primary GIST in the duodenum or proximal jejunum within 20 cm of Treitz's ligament between January 2008 and December 2023. The patients were divided into two groups: non-bypass (without gastrojejunostomy) and bypass (with gastrojejunostomy and Braun's jejunojejunostomy). Perioperative characteristics and postoperative complications were analyzed.

Results: Among the 50 patients, 27 underwent duodenojejunostomies without gastrojejunostomies and 23 with gastrojejunostomies and Braun's jejunojejunostomies. The incidence of grade B-C DGE was significantly lower in the bypass group (43.5% vs. 74.1%, p = 0.028). In addition, non-bypass surgery was an independent risk factor for increased grade B-C DGE (OR 3.67, 95% CI 1.07-12.64, p = 0.039). The bypass group showed a trend towards a shorter postoperative hospital stay (median: 14 days, range: 10-56) compared to the non-bypass group (median: 28 days, range: 6-75), but this difference did not reach statistical significance (p = 0.070). Operative time (min) was significantly longer in the multi-visceral resection group (381.0 ± 108.8 vs. 227.3 ± 87.6, p < 0.001), for tumors ≥ 6.3 cm compared to < 6.3 cm (337.0 ± 116.4 vs. 228.3 ± 99.8, p = 0.002), and in patients with positive preoperative symptoms versus asymptomatic patients (319.9 ± 118.0 vs. 210.2 ± 90.3, p = 0.031).

Conclusion: The addition of gastrojejunostomy and Braun's jejunojejunostomy in distal segmental duodenectomy can reduce the incidence of grade B-C DGE, potentially facilitating timely adjuvant imatinib therapy. Future multicenter studies are needed to confirm these findings.

背景:目的:研究胃空肠造口术是否能降低十二指肠和空肠近端胃肠间质瘤(GIST)远端十二指肠切除术后胃排空延迟(DGE)的发生率:这项对北京大学肿瘤医院GIST数据库的回顾性研究纳入了2008年1月至2023年12月期间因十二指肠或空肠近端Treitz韧带20厘米范围内的原发性GIST而接受远段十二指肠切除术的50例患者。患者分为两组:非分流组(无胃空肠吻合术)和分流组(有胃空肠吻合术和布劳恩空肠吻合术)。对围手术期特征和术后并发症进行了分析:结果:在50名患者中,有27人接受了十二指肠空肠吻合术,但没有接受胃空肠吻合术;有23人接受了胃空肠吻合术和布劳恩空肠吻合术。分流手术组的 B-C 级 DGE 发生率明显较低(43.5% 对 74.1%,P = 0.028)。此外,非搭桥手术是导致 B-C 级 DGE 增加的独立风险因素(OR 3.67,95% CI 1.07-12.64,p = 0.039)。与非搭桥手术组(中位数:28 天,范围:6-75 天)相比,搭桥手术组的术后住院时间有缩短的趋势(中位数:14 天,范围:10-56 天),但这一差异未达到统计学意义(P = 0.070)。在十二指肠远段切除术中增加胃空肠吻合术和布劳恩空肠吻合术可降低 B-C 级 DGE 的发生率,从而有助于及时进行伊马替尼辅助治疗。今后还需要开展多中心研究来证实这些发现。
{"title":"An additional gastrojejunostomy may reduce the incidence of moderate and severe delayed gastric emptying after distal segmental duodenectomy for gastrointestinal stromal tumors.","authors":"Wei-Wei Jia, Jian-Hui Wu, Cui Yang, Dao-Ning Liu, Xiao-Peng Wang, Rong-Ze Sun, Cheng-Peng Li, Chun-Yi Hao","doi":"10.1186/s12957-024-03585-1","DOIUrl":"10.1186/s12957-024-03585-1","url":null,"abstract":"<p><strong>Background: </strong>To investigate whether an additional gastrojejunostomy reduces the incidence of delayed gastric emptying (DGE) following a distal segmental duodenectomy for duodenal and proximal jejunal gastrointestinal stromal tumors (GIST).</p><p><strong>Materials and methods: </strong>This retrospective review of the GIST database at Peking University Cancer Hospital included 50 patients who underwent distal segmental duodenectomies for primary GIST in the duodenum or proximal jejunum within 20 cm of Treitz's ligament between January 2008 and December 2023. The patients were divided into two groups: non-bypass (without gastrojejunostomy) and bypass (with gastrojejunostomy and Braun's jejunojejunostomy). Perioperative characteristics and postoperative complications were analyzed.</p><p><strong>Results: </strong>Among the 50 patients, 27 underwent duodenojejunostomies without gastrojejunostomies and 23 with gastrojejunostomies and Braun's jejunojejunostomies. The incidence of grade B-C DGE was significantly lower in the bypass group (43.5% vs. 74.1%, p = 0.028). In addition, non-bypass surgery was an independent risk factor for increased grade B-C DGE (OR 3.67, 95% CI 1.07-12.64, p = 0.039). The bypass group showed a trend towards a shorter postoperative hospital stay (median: 14 days, range: 10-56) compared to the non-bypass group (median: 28 days, range: 6-75), but this difference did not reach statistical significance (p = 0.070). Operative time (min) was significantly longer in the multi-visceral resection group (381.0 ± 108.8 vs. 227.3 ± 87.6, p < 0.001), for tumors ≥ 6.3 cm compared to < 6.3 cm (337.0 ± 116.4 vs. 228.3 ± 99.8, p = 0.002), and in patients with positive preoperative symptoms versus asymptomatic patients (319.9 ± 118.0 vs. 210.2 ± 90.3, p = 0.031).</p><p><strong>Conclusion: </strong>The addition of gastrojejunostomy and Braun's jejunojejunostomy in distal segmental duodenectomy can reduce the incidence of grade B-C DGE, potentially facilitating timely adjuvant imatinib therapy. Future multicenter studies are needed to confirm these findings.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"303"},"PeriodicalIF":2.5,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastric glomus tumor with uncertain malignant potential: case report of a rare cause of upper gastrointestinal bleeding. 具有不确定恶性潜能的胃腺肿瘤:上消化道出血罕见病例报告。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-13 DOI: 10.1186/s12957-024-03563-7
Roland Fejes, Kitti Szonja Gyorgyev, Csaba Góg, László Krenács, Tamás Zombori, Zsófia Eszter Széll, Zsófia Balajthy, Tamás Pancsa, Zsolt Simonka

Background: Glomus tumors (GTs) are mesenchymal neoplasms that are typically benign. Gastric GTs are uncommon and occur mainly in the upper gastrointestinal tract. Malignant gastric GTs are extremely rare, constituting less than 1% of gastric tumors. Because their features are similar to those of other tumors found in the same gastrointestinal region, such as stromal tumors, leiomyomas, lymphomas, and lipomas, the diagnosis is challenging.

Case presentation: A 52-year-old male patient presented with fatigue and melena. The initial endoscopic examination did not locate any source of bleeding. Six months later, pan-gastroscopy, performed due to progressive microcytic anemia, revealed a 40 × 30 mm polypoid lesion with deep ulcerations; histopathological analysis confirmed that it was a gastric GT with expression of alpha-actin and cadherin 17 and a Ki-67 index of 20%. The patient delayed surgical therapy until his symptoms worsened. Laparoscopic sleeve resection revealed a 65 × 45 × 25 mm tumor, and secondary immunohistochemical analysis revealed extensive spread into the mucosa and subserosa. Focally, the tumor bulged into some large veins. Genetic examination with RNA isolation further supported the histopathological diagnosis of gastric GT with uncertain malignant potential.

Conclusions: This case underscores the diagnostic challenges posed by gastric GTs because they are rare and their clinical features are similar to those of other gastric tumors. Thorough histopathological and molecular analysis is essential for an accurate diagnosis. Surgical intervention remains the primary therapeutic approach. This case also emphasizes the need for long-term follow-up due to the potential for recurrence and malignancy.

背景:粘液瘤(GTs)是一种间叶肿瘤,通常为良性。胃GTs并不常见,主要发生在上消化道。恶性胃粘膜瘤极为罕见,仅占胃肿瘤的不到1%。由于其特征与在同一胃肠道区域发现的其他肿瘤(如间质瘤、肌瘤、淋巴瘤和脂肪瘤)相似,因此诊断具有挑战性:一名 52 岁的男性患者因乏力和腹泻就诊。最初的内镜检查未发现任何出血源。六个月后,由于进行性小红细胞贫血而进行了全胃镜检查,发现了一个 40 × 30 毫米的息肉样病变,伴有深溃疡;组织病理学分析证实这是一个胃 GT,表达α-肌动蛋白和干酪素 17,Ki-67 指数为 20%。患者推迟了手术治疗,直到症状恶化。腹腔镜袖状切除术显示肿瘤大小为 65 × 45 × 25 毫米,二次免疫组化分析显示肿瘤向粘膜和粘膜下广泛扩散。肿瘤局部隆起到一些大静脉。通过分离 RNA 进行的遗传学检查进一步支持了胃 GT 的组织病理学诊断,但恶性可能性不确定:本病例强调了胃GT给诊断带来的挑战,因为胃GT非常罕见,而且其临床特征与其他胃肿瘤相似。彻底的组织病理学和分子分析对于准确诊断至关重要。手术干预仍然是主要的治疗方法。本病例还强调了长期随访的必要性,因为它有可能复发和恶变。
{"title":"Gastric glomus tumor with uncertain malignant potential: case report of a rare cause of upper gastrointestinal bleeding.","authors":"Roland Fejes, Kitti Szonja Gyorgyev, Csaba Góg, László Krenács, Tamás Zombori, Zsófia Eszter Széll, Zsófia Balajthy, Tamás Pancsa, Zsolt Simonka","doi":"10.1186/s12957-024-03563-7","DOIUrl":"10.1186/s12957-024-03563-7","url":null,"abstract":"<p><strong>Background: </strong>Glomus tumors (GTs) are mesenchymal neoplasms that are typically benign. Gastric GTs are uncommon and occur mainly in the upper gastrointestinal tract. Malignant gastric GTs are extremely rare, constituting less than 1% of gastric tumors. Because their features are similar to those of other tumors found in the same gastrointestinal region, such as stromal tumors, leiomyomas, lymphomas, and lipomas, the diagnosis is challenging.</p><p><strong>Case presentation: </strong>A 52-year-old male patient presented with fatigue and melena. The initial endoscopic examination did not locate any source of bleeding. Six months later, pan-gastroscopy, performed due to progressive microcytic anemia, revealed a 40 × 30 mm polypoid lesion with deep ulcerations; histopathological analysis confirmed that it was a gastric GT with expression of alpha-actin and cadherin 17 and a Ki-67 index of 20%. The patient delayed surgical therapy until his symptoms worsened. Laparoscopic sleeve resection revealed a 65 × 45 × 25 mm tumor, and secondary immunohistochemical analysis revealed extensive spread into the mucosa and subserosa. Focally, the tumor bulged into some large veins. Genetic examination with RNA isolation further supported the histopathological diagnosis of gastric GT with uncertain malignant potential.</p><p><strong>Conclusions: </strong>This case underscores the diagnostic challenges posed by gastric GTs because they are rare and their clinical features are similar to those of other gastric tumors. Thorough histopathological and molecular analysis is essential for an accurate diagnosis. Surgical intervention remains the primary therapeutic approach. This case also emphasizes the need for long-term follow-up due to the potential for recurrence and malignancy.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"299"},"PeriodicalIF":2.5,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single stage direct -to- implant breast reconstruction following mastectomy (The use of Ultrapro® Mesh). 乳房切除术后单期直接植入乳房再造(使用 Ultrapro® 网片)。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-12 DOI: 10.1186/s12957-024-03576-2
Maher H Ibraheem, Omnia Mohammed Mohammed Essawy, Inas Moaz, Zakaria Saeed Mohammed Osman, Yomna Sherif Omara, Amr Farouk, Ahmed Amin, Yasmine Hany Abdel Moamen Elzohery, Mohammed Gamal Ahmed Awad

Background: Immediate breast reconstruction (IBR) with direct to implant (DTI) is the preferred method of reconstruction by many surgeons and patients, however, acellular dermal matrix (ADM) and other synthetic meshes are expensive especially in low- and middle-income countries. AIM OF THE WORK: To evaluate the technique, indications, aesthetic outcomes, and short and long-term complications of DTI breast reconstruction performed with Ultrapro®, a low-cost alternative mesh to ADM and other synthetic meshes.

Methods: Our study is a prospective cohort study that was conducted on 133 patients who experienced IBR following nipple-sparing mastectomy (NSM) or skin sparing mastectomy (SSM) using silicone implants and Ultrapro® mesh between December 2020 and December 2023. Techniques used were either sub-pectoral or pre-pectoral, evaluating aesthetic outcome, complication rate and patient satisfaction using breast Q questionnaire.

Results: We included 133 patients (141 breasts) with a median age of 39 years. Mean duration of follow up: 20.364 ± 5.39 months. The sub-pectoral and the pre pectoral techniques were used for 80 breasts and 61 breasts respectively. We used the Ultrapro® mesh in all our patients. Smooth round silicone implants were used. The overall Major complications rate was 16.3%. 8 implants (5.7%) were lost within 6 months post-operatively while 2 implants were removed in the late post-operative period (after 6 months) one due to rupture and the other due to local recurrence. Capsular contracture Baker 3 and 4 was observed in 36 breasts (25%), 31 of them had post mastectomy radiotherapy treatment. 11 (7.8%) were managed by capsulotomies and re-insertion of the same implant. Radiotherapy was a significant risk factors for major complications and capsular contracture with p value of (0.01) and (0.0001) respectively.

Conclusion: DTI in properly selected patients offers excellent outcomes and patient satisfaction. The complication rate is low and improves with the experience of the surgeon. The Ultrapro® mesh is a safe, low-cost alternative to ADM or other synthetic meshes especially in low socioeconomic countries. Radiotherapy is a significant risk factor for major complications and capsular contractures.

背景:直接植入假体(DTI)的即刻乳房再造(IBR)是许多外科医生和患者首选的再造方法,然而,细胞外基质(ADM)和其他合成网格价格昂贵,尤其是在中低收入国家。工作目的评估使用 Ultrapro® 进行 DTI 乳房重建的技术、适应症、美学效果以及短期和长期并发症:我们的研究是一项前瞻性队列研究,对象是在 2020 年 12 月至 2023 年 12 月期间使用硅胶假体和 Ultrapro® 网片进行乳头保留乳房切除术(NSM)或皮肤保留乳房切除术(SSM)后经历 IBR 的 133 名患者。采用的技术为胸大肌下或胸大肌前,使用乳房 Q 问卷评估美学效果、并发症发生率和患者满意度:我们共纳入了 133 名患者(141 个乳房),中位年龄为 39 岁。平均随访时间20.364 ± 5.39个月。分别对 80 个乳房和 61 个乳房采用了胸骨下技术和胸骨前技术。我们为所有患者使用了 Ultrapro® 网片。使用光滑的圆形硅胶假体。主要并发症总发生率为 16.3%。8个假体(5.7%)在术后6个月内丢失,2个假体在术后晚期(6个月后)被取出,一个是由于破裂,另一个是由于局部复发。有 36 个乳房(25%)出现了 Baker 3 和 4 级囊膜挛缩,其中 31 个乳房在乳房切除术后接受了放射治疗。11例(7.8%)通过切除囊肿和重新植入相同的假体进行了处理。放疗是主要并发症和包膜挛缩的重要风险因素,P 值分别为 (0.01) 和 (0.0001):结论:经过适当选择的 DTI 患者可获得极佳的疗效和患者满意度。并发症发生率较低,并随着外科医生经验的增加而提高。Ultrapro® 网片是 ADM 或其他合成网片的安全、低成本替代品,尤其是在社会经济水平较低的国家。放疗是导致重大并发症和囊膜挛缩的重要风险因素。
{"title":"Single stage direct -to- implant breast reconstruction following mastectomy (The use of Ultrapro® Mesh).","authors":"Maher H Ibraheem, Omnia Mohammed Mohammed Essawy, Inas Moaz, Zakaria Saeed Mohammed Osman, Yomna Sherif Omara, Amr Farouk, Ahmed Amin, Yasmine Hany Abdel Moamen Elzohery, Mohammed Gamal Ahmed Awad","doi":"10.1186/s12957-024-03576-2","DOIUrl":"10.1186/s12957-024-03576-2","url":null,"abstract":"<p><strong>Background: </strong>Immediate breast reconstruction (IBR) with direct to implant (DTI) is the preferred method of reconstruction by many surgeons and patients, however, acellular dermal matrix (ADM) and other synthetic meshes are expensive especially in low- and middle-income countries. AIM OF THE WORK: To evaluate the technique, indications, aesthetic outcomes, and short and long-term complications of DTI breast reconstruction performed with Ultrapro®, a low-cost alternative mesh to ADM and other synthetic meshes.</p><p><strong>Methods: </strong>Our study is a prospective cohort study that was conducted on 133 patients who experienced IBR following nipple-sparing mastectomy (NSM) or skin sparing mastectomy (SSM) using silicone implants and Ultrapro® mesh between December 2020 and December 2023. Techniques used were either sub-pectoral or pre-pectoral, evaluating aesthetic outcome, complication rate and patient satisfaction using breast Q questionnaire.</p><p><strong>Results: </strong>We included 133 patients (141 breasts) with a median age of 39 years. Mean duration of follow up: 20.364 ± 5.39 months. The sub-pectoral and the pre pectoral techniques were used for 80 breasts and 61 breasts respectively. We used the Ultrapro® mesh in all our patients. Smooth round silicone implants were used. The overall Major complications rate was 16.3%. 8 implants (5.7%) were lost within 6 months post-operatively while 2 implants were removed in the late post-operative period (after 6 months) one due to rupture and the other due to local recurrence. Capsular contracture Baker 3 and 4 was observed in 36 breasts (25%), 31 of them had post mastectomy radiotherapy treatment. 11 (7.8%) were managed by capsulotomies and re-insertion of the same implant. Radiotherapy was a significant risk factors for major complications and capsular contracture with p value of (0.01) and (0.0001) respectively.</p><p><strong>Conclusion: </strong>DTI in properly selected patients offers excellent outcomes and patient satisfaction. The complication rate is low and improves with the experience of the surgeon. The Ultrapro® mesh is a safe, low-cost alternative to ADM or other synthetic meshes especially in low socioeconomic countries. Radiotherapy is a significant risk factor for major complications and capsular contractures.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"297"},"PeriodicalIF":2.5,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine. 急性髓性白血病患者体内的 OXPHOS 介质:个性化医疗的预后生物标志物和治疗靶点。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-12 DOI: 10.1186/s12957-024-03581-5
Amal Kamal Abdel-Aziz

Background: Despite significant advances in comprehending its tumorigenic role, the prognostic and therapeutic potential of targeting oxidative phosphorylation (OXPHOS) in acute myeloid leukemia (AML) remain obscure.

Methods: The prognostic value of ~ 200 mitochondrial/OXPHOS genes as candidate biomarkers was examined in AML patients over ~ 10 years follow-up using Kaplan-Meier and Cox regression analyses. Furthermore, the transcript levels of the assessed markers were inspected in healthy bone marrow tissues and the dependencies of AML cells on the assessed genes were examined.

Results: Elevated levels of NADH:ubiquinone oxidoreductase subunit A6 (NDUFA6), succinate dehydrogenase complex flavoprotein subunit A (SDHA), solute carrier family 25 member 12 (SLC25A12), electron transfer flavoprotein subunit beta (ETFB), carnitine palmitoyltransferase 1A (CPT1A) and glutathione peroxidase 4 (GPX4) were associated with poor overall survival of AML patients. SLC25A12, ETFB and CPT1A were overexpressed in AML compared to healthy tissues. Cytochrome B5 type A (CYB5A)high, SLC25A12high and GPX4high AML patients displayed higher levels of circulating and engrafted blasts compared to low-expressing cohorts. NPM1 and SRSF2 mutations were frequent in SDHAlow and CPT1Alow AML patients respectively. FLT3-ITD, NPM1 and IDH1 mutations were prevalent in CPT1Ahigh AML patients. FLT3-ITD AMLs were more dependent on OXPHOS.

Conclusions: This study identifies NDUFA6 and SDHA as novel companion prognostic biomarkers which might present a rational strategy for personalized therapy of AML patients.

背景:尽管在理解氧化磷酸化(OXPHOS)的致瘤作用方面取得了重大进展,但针对急性髓性白血病(AML)的氧化磷酸化(OXPHOS)的预后和治疗潜力仍不明显:方法:使用 Kaplan-Meier 和 Cox 回归分析法研究了约 200 个线粒体/OXPHOS 基因作为候选生物标志物对随访约 10 年的急性髓性白血病患者的预后价值。此外,还检测了健康骨髓组织中评估标志物的转录水平,并研究了 AML 细胞对评估基因的依赖性:结果:NADH:泛醌氧化还原酶亚基A6(NDUFA6)、琥珀酸脱氢酶复合物黄蛋白亚基A(SDHA)、溶质运载家族25成员12(SLC25A12)、电子传递黄蛋白亚基β(ETFB)、肉碱棕榈酰基转移酶1A(CPT1A)和谷胱甘肽过氧化物酶4(GPX4)的水平升高与急性髓细胞白血病患者的总生存率较低有关。与健康组织相比,SLC25A12、ETFB 和 CPT1A 在急性髓细胞性白血病中过表达。与低表达组相比,细胞色素B5 A型(CYB5A)高、SLC25A12高和GPX4高的急性髓细胞性白血病患者的循环和移植囊泡水平更高。NPM1和SRSF2突变分别在SDHA低和CPT1A低的急性髓细胞性白血病患者中很常见。FLT3-ITD、NPM1和IDH1突变在CPT1A高的急性髓细胞性白血病患者中很常见。FLT3-ITD型急性髓细胞性白血病更依赖于OXPHOS:本研究发现NDUFA6和SDHA是新型的辅助预后生物标志物,可为急性髓细胞性白血病患者的个性化治疗提供合理的策略。
{"title":"OXPHOS mediators in acute myeloid leukemia patients: Prognostic biomarkers and therapeutic targets for personalized medicine.","authors":"Amal Kamal Abdel-Aziz","doi":"10.1186/s12957-024-03581-5","DOIUrl":"10.1186/s12957-024-03581-5","url":null,"abstract":"<p><strong>Background: </strong>Despite significant advances in comprehending its tumorigenic role, the prognostic and therapeutic potential of targeting oxidative phosphorylation (OXPHOS) in acute myeloid leukemia (AML) remain obscure.</p><p><strong>Methods: </strong>The prognostic value of ~ 200 mitochondrial/OXPHOS genes as candidate biomarkers was examined in AML patients over ~ 10 years follow-up using Kaplan-Meier and Cox regression analyses. Furthermore, the transcript levels of the assessed markers were inspected in healthy bone marrow tissues and the dependencies of AML cells on the assessed genes were examined.</p><p><strong>Results: </strong>Elevated levels of NADH:ubiquinone oxidoreductase subunit A6 (NDUFA6), succinate dehydrogenase complex flavoprotein subunit A (SDHA), solute carrier family 25 member 12 (SLC25A12), electron transfer flavoprotein subunit beta (ETFB), carnitine palmitoyltransferase 1A (CPT1A) and glutathione peroxidase 4 (GPX4) were associated with poor overall survival of AML patients. SLC25A12, ETFB and CPT1A were overexpressed in AML compared to healthy tissues. Cytochrome B5 type A (CYB5A)<sup>high</sup>, SLC25A12<sup>high</sup> and GPX4<sup>high</sup> AML patients displayed higher levels of circulating and engrafted blasts compared to low-expressing cohorts. NPM1 and SRSF2 mutations were frequent in SDHA<sup>low</sup> and CPT1A<sup>low</sup> AML patients respectively. FLT3-ITD, NPM1 and IDH1 mutations were prevalent in CPT1A<sup>high</sup> AML patients. FLT3-ITD AMLs were more dependent on OXPHOS.</p><p><strong>Conclusions: </strong>This study identifies NDUFA6 and SDHA as novel companion prognostic biomarkers which might present a rational strategy for personalized therapy of AML patients.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"298"},"PeriodicalIF":2.5,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021. 高体重指数对中国胆囊癌和胆道癌负担的影响:1990 年至 2021 年趋势的综合分析。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-12 DOI: 10.1186/s12957-024-03582-4
Zhouwei Zhan, Xiamei Chen, Shaohua Xu, Qifei Li, Jiami Yu, Zengqing Guo, Bijuan Chen

Background: Gallbladder and biliary tract cancer (GBTC) is a significant health burden in China, exacerbated by the rising prevalence of high body mass index (BMI). Understanding the trends and factors contributing to mortality and disability associated with GBTC is crucial for targeted public health interventions.

Methods: We utilized data from the Global Burden of Disease (GBD) Study to assess the burden of GBTC attributable to high BMI in China from 1990 to 2021. Age-standardized rates of deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) were analyzed. Joinpoint regression and decomposition analyses were conducted to evaluate trends and identify contributing factors, including aging, population growth, and epidemiological changes. Gender-specific differences were also assessed.

Results: In 2021, GBTC deaths attributable to high BMI in China reached 4,053, with males experiencing a higher overall burden than females, particularly in older age groups. While females showed a higher mortality and overall burden in the 60 to 79 age range, this trend reversed in older age brackets, with males experiencing steeper increases in mortality and disability-related indicators beyond age 80. The age-standardized DALYs rate mirrored this pattern, with higher rates in males in advanced age groups. From 1990 to 2021, China saw a steady increase in GBTC burden attributable to high BMI, contrasting with a global decline. Joinpoint analysis indicated marked rises in mortality and DALYs rates after 2005, especially in males. Decomposition analysis identified population growth and aging as major drivers of increased deaths, while epidemiological changes primarily contributed to rising DALYs, with a stronger impact observed in males.

Conclusions: The burden of GBTC attributable to high BMI in China has increased substantially over the last three decades, driven by population growth, aging, and epidemiological shifts. The trends highlight a growing gender disparity, with males experiencing a greater rise in mortality and disability. Public health strategies targeting obesity and metabolic risk factors are critical to mitigating the increasing GBTC burden.

背景:胆囊癌和胆道癌(GBTC)是中国的一项重大健康负担,高体重指数(BMI)的上升加剧了这一负担。了解与胆囊癌相关的死亡率和致残率的趋势和因素,对于采取有针对性的公共卫生干预措施至关重要:我们利用全球疾病负担(GBD)研究的数据,评估了 1990 年至 2021 年中国因高体重指数导致的 GBTC 负担。我们分析了年龄标准化死亡率、残疾调整生命年(DALYs)、残疾生存年(YLDs)和生命损失年(YLLs)。通过联结点回归和分解分析来评估趋势并确定促成因素,包括老龄化、人口增长和流行病学变化。此外,还对性别差异进行了评估:2021年,中国因高体重指数导致的GBTC死亡人数达到4053人,男性的总体负担高于女性,尤其是在老年群体中。虽然女性在 60 至 79 岁年龄段的死亡率和总体负担较高,但这一趋势在更高年龄段发生逆转,男性在 80 岁以后的死亡率和残疾相关指标急剧上升。年龄标准化残疾调整寿命年数率也反映了这一模式,男性在高年龄段的比率更高。从 1990 年到 2021 年,中国因高体重指数造成的 GBTC 负担稳步上升,与全球下降形成鲜明对比。接合点分析表明,2005 年后死亡率和残疾调整寿命年数率明显上升,尤其是男性。分解分析表明,人口增长和老龄化是导致死亡人数增加的主要原因,而流行病学的变化则是导致残疾调整寿命年数增加的主要原因,对男性的影响更大:结论:在过去的三十年中,受人口增长、老龄化和流行病学变化的影响,中国因高体重指数导致的GBTC负担大幅增加。这些趋势凸显了性别差异的不断扩大,男性的死亡率和残疾率上升幅度更大。针对肥胖和代谢风险因素的公共卫生策略对于减轻日益加重的 GBTC 负担至关重要。
{"title":"Impact of high body mass index on gallbladder and biliary tract cancer burden in China: a comprehensive analysis of trends from 1990 to 2021.","authors":"Zhouwei Zhan, Xiamei Chen, Shaohua Xu, Qifei Li, Jiami Yu, Zengqing Guo, Bijuan Chen","doi":"10.1186/s12957-024-03582-4","DOIUrl":"10.1186/s12957-024-03582-4","url":null,"abstract":"<p><strong>Background: </strong>Gallbladder and biliary tract cancer (GBTC) is a significant health burden in China, exacerbated by the rising prevalence of high body mass index (BMI). Understanding the trends and factors contributing to mortality and disability associated with GBTC is crucial for targeted public health interventions.</p><p><strong>Methods: </strong>We utilized data from the Global Burden of Disease (GBD) Study to assess the burden of GBTC attributable to high BMI in China from 1990 to 2021. Age-standardized rates of deaths, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs) were analyzed. Joinpoint regression and decomposition analyses were conducted to evaluate trends and identify contributing factors, including aging, population growth, and epidemiological changes. Gender-specific differences were also assessed.</p><p><strong>Results: </strong>In 2021, GBTC deaths attributable to high BMI in China reached 4,053, with males experiencing a higher overall burden than females, particularly in older age groups. While females showed a higher mortality and overall burden in the 60 to 79 age range, this trend reversed in older age brackets, with males experiencing steeper increases in mortality and disability-related indicators beyond age 80. The age-standardized DALYs rate mirrored this pattern, with higher rates in males in advanced age groups. From 1990 to 2021, China saw a steady increase in GBTC burden attributable to high BMI, contrasting with a global decline. Joinpoint analysis indicated marked rises in mortality and DALYs rates after 2005, especially in males. Decomposition analysis identified population growth and aging as major drivers of increased deaths, while epidemiological changes primarily contributed to rising DALYs, with a stronger impact observed in males.</p><p><strong>Conclusions: </strong>The burden of GBTC attributable to high BMI in China has increased substantially over the last three decades, driven by population growth, aging, and epidemiological shifts. The trends highlight a growing gender disparity, with males experiencing a greater rise in mortality and disability. Public health strategies targeting obesity and metabolic risk factors are critical to mitigating the increasing GBTC burden.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"296"},"PeriodicalIF":2.5,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological analysis of sclerosing haemangiomatoid nodular transformation of the spleen: analysis of three cases and a literature review. 脾脏硬化性血管瘤样结节变的临床病理分析:三例病例分析和文献综述。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-07 DOI: 10.1186/s12957-024-03580-6
Jiafei Zeng, Jin Li, Shuai Luo, Jinjing Wang

Objective: To examine the clinicopathological features, immunohistochemical profiles, and differential diagnosis of sclerosing angiomatiod nodular transformation (SANT).

Methods: Three cases of SANT of the spleen, diagnosed between 2014 and 2023 at the Affiliated Hospital of Zunyi Medical University, were analysed. Pathological features were assessed using haematoxylin and eosin staining, followed by immunohistochemistry with the EnVision system. Additionally, a review of relevant literature was conducted.

Results: The study included one male and two female patients aged 40-55 years, with a median age of 47.5 years. All lesions were solitary, with tumour diameters ranging from 4 to 7.4 cm (mean 5.7 cm). Gross examination demonstrated that the masses were well-demarcated from the surrounding splenic tissue, with no evident capsule. The cut surfaces of the masses exhibited irregular, porcelain-white nodules that were tough in consistency, with some areas intermingling with splenic tissue. Microscopic examination revealed round or circular nodules comprising multiple slit-like or sinusoidal capillaries, separated by concentric collagen fibres. The nodules exhibited chronic inflammatory cell infiltration, calcification, haemosiderin deposition, and fibrous connective tissue with hyaline or mucoid changes. Immunohistochemical analysis demonstrated differential expression of markers, including cluster of differentiation (CD) 34, CD31, and CD8, within the sinusoidal nodule areas. Periodic acid-Schiff staining was positive for perinodular collagen deposits, while reticulin staining highlighted nodule profiles and intranodular vessels. None of the patients experienced postoperative recurrence or metastasis, and one patient was on aspirin for thrombocytosis.

Conclusion: SANT of the spleen is generally considered a rare, benign lesion with angioma-like characteristics. It exhibits exhibiting distinctive histomorphological features within the red pulp. Understanding the differential diagnosis is crucial to prevent missed or incorrect diagnoses.

目的研究硬化性血管瘤结节性转化(SANT)的临床病理特征、免疫组化特征及鉴别诊断:方法:分析遵义医学院附属医院2014年至2023年间确诊的3例脾脏SANT病例。方法:分析遵义医学院附属医院在2014年至2023年期间确诊的3例SANT病例,使用血红素和伊红染色法评估病理特征,然后使用EnVision系统进行免疫组化。此外,还查阅了相关文献:研究包括一名男性和两名女性患者,年龄在 40-55 岁之间,中位年龄为 47.5 岁。所有病变均为单发,肿瘤直径为 4 至 7.4 厘米(平均 5.7 厘米)。大体检查显示,肿块与周围脾脏组织分界清楚,无明显包囊。肿块的切面呈不规则的瓷白色结节,质地坚韧,部分区域与脾脏组织混杂在一起。显微镜检查发现,圆形或环形结节由多条狭缝状或窦状毛细血管组成,中间由同心胶原纤维隔开。结节表现为慢性炎症细胞浸润、钙化、血色素沉积、纤维结缔组织呈透明或粘液状变化。免疫组化分析表明,在窦状结节区域内,分化簇(CD)34、CD31 和 CD8 等标记物的表达存在差异。定期酸-希夫染色显示结节周围胶原沉积呈阳性,而网状纤维素染色则突出显示了结节轮廓和结节内血管。没有一名患者出现术后复发或转移,一名患者因血小板增多而服用阿司匹林:结论:脾脏 SANT 一般被认为是一种罕见的良性病变,具有血管瘤样特征。结论:脾脏 SANT 一般被认为是一种罕见的良性病变,具有血管瘤样特征,在红髓内表现出独特的组织形态学特征。了解鉴别诊断对于防止漏诊或误诊至关重要。
{"title":"Clinicopathological analysis of sclerosing haemangiomatoid nodular transformation of the spleen: analysis of three cases and a literature review.","authors":"Jiafei Zeng, Jin Li, Shuai Luo, Jinjing Wang","doi":"10.1186/s12957-024-03580-6","DOIUrl":"10.1186/s12957-024-03580-6","url":null,"abstract":"<p><strong>Objective: </strong>To examine the clinicopathological features, immunohistochemical profiles, and differential diagnosis of sclerosing angiomatiod nodular transformation (SANT).</p><p><strong>Methods: </strong>Three cases of SANT of the spleen, diagnosed between 2014 and 2023 at the Affiliated Hospital of Zunyi Medical University, were analysed. Pathological features were assessed using haematoxylin and eosin staining, followed by immunohistochemistry with the EnVision system. Additionally, a review of relevant literature was conducted.</p><p><strong>Results: </strong>The study included one male and two female patients aged 40-55 years, with a median age of 47.5 years. All lesions were solitary, with tumour diameters ranging from 4 to 7.4 cm (mean 5.7 cm). Gross examination demonstrated that the masses were well-demarcated from the surrounding splenic tissue, with no evident capsule. The cut surfaces of the masses exhibited irregular, porcelain-white nodules that were tough in consistency, with some areas intermingling with splenic tissue. Microscopic examination revealed round or circular nodules comprising multiple slit-like or sinusoidal capillaries, separated by concentric collagen fibres. The nodules exhibited chronic inflammatory cell infiltration, calcification, haemosiderin deposition, and fibrous connective tissue with hyaline or mucoid changes. Immunohistochemical analysis demonstrated differential expression of markers, including cluster of differentiation (CD) 34, CD31, and CD8, within the sinusoidal nodule areas. Periodic acid-Schiff staining was positive for perinodular collagen deposits, while reticulin staining highlighted nodule profiles and intranodular vessels. None of the patients experienced postoperative recurrence or metastasis, and one patient was on aspirin for thrombocytosis.</p><p><strong>Conclusion: </strong>SANT of the spleen is generally considered a rare, benign lesion with angioma-like characteristics. It exhibits exhibiting distinctive histomorphological features within the red pulp. Understanding the differential diagnosis is crucial to prevent missed or incorrect diagnoses.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"291"},"PeriodicalIF":2.5,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing effects of short-term smoking cessation on lung cancer postoperative complications: a systematic review and meta-analysis. 短期戒烟对肺癌术后并发症的时间效应:系统综述和荟萃分析。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-07 DOI: 10.1186/s12957-024-03577-1
Zhan Zhang, Yue Zhao, Jianhao Qiu, Zhenyi Li, Lin Li, Hui Tian

Background: Preoperative smoking cessation may reduce postoperative complications in patients with lung cancer. However, the optimal duration of short-term preoperative smoking cessation remains unclear.

Methods: Three databases, PubMed, Embase, and the Cochrane Library, were searched for studies published up to April 5, 2024. The Newcastle-Ottawa scale was used to assess the risk of bias. The included studies compared the incidence of postoperative complications between patients with different preoperative smoking cessation times and those with persistent preoperative smoking. A meta-analysis of postoperative complications and events such as pneumonia was performed in patients with lung cancer.

Results: Fourteen studies met the inclusion criteria and included a total of 50,741 patients who had undergone pulmonary resection. The meta-analysis showed that preoperative smoking cessation of > 2 weeks and < 1 month did not reduce the incidence of postoperative complications (odds ratio [OR] 1.05; 95% confidence interval [CI] 0.76-1.44; P = 0.78) and pneumonia (OR 0.98; 95% CI 0.60-1.61; P = 0.95). Moreover, preoperative smoking cessation for > 1 month was effective in reducing the incidence of postoperative complications (OR 0.72; 95% CI 0.63-0.83; P < 0.01) as well as pneumonia (OR 0.80; 95% CI 0.49-1.33; P = 0.40).

Conclusions: This meta-analysis suggests that preoperative smoking cessation for > 1 month is effective in reducing complications and pneumonia after pulmonary resection in patients with lung cancer, especially as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery become more common.

背景:术前戒烟可减少肺癌患者的术后并发症:术前戒烟可减少肺癌患者的术后并发症。然而,术前短期戒烟的最佳持续时间仍不明确:方法:检索了 PubMed、Embase 和 Cochrane Library 三个数据库中截至 2024 年 4 月 5 日发表的研究。采用纽卡斯尔-渥太华量表评估偏倚风险。纳入的研究比较了不同术前戒烟时间的患者和术前持续吸烟的患者的术后并发症发生率。对肺癌患者的术后并发症和肺炎等事件进行了荟萃分析:结果:14 项研究符合纳入标准,共纳入 50,741 名接受肺切除术的患者。荟萃分析表明,术前戒烟时间大于 2 周和 1 个月可有效降低术后并发症的发生率(OR 0.72;95% CI 0.63-0.83;P 结论:荟萃分析表明,术前戒烟时间大于 2 周和 1 个月可有效降低术后并发症的发生率(OR 0.72;95% CI 0.63-0.83;P):该荟萃分析表明,术前戒烟 > 1 个月可有效减少肺癌患者肺切除术后并发症和肺炎的发生,尤其是随着视频辅助胸腔镜手术(VATS)和机器人辅助手术的普及。
{"title":"Timing effects of short-term smoking cessation on lung cancer postoperative complications: a systematic review and meta-analysis.","authors":"Zhan Zhang, Yue Zhao, Jianhao Qiu, Zhenyi Li, Lin Li, Hui Tian","doi":"10.1186/s12957-024-03577-1","DOIUrl":"10.1186/s12957-024-03577-1","url":null,"abstract":"<p><strong>Background: </strong>Preoperative smoking cessation may reduce postoperative complications in patients with lung cancer. However, the optimal duration of short-term preoperative smoking cessation remains unclear.</p><p><strong>Methods: </strong>Three databases, PubMed, Embase, and the Cochrane Library, were searched for studies published up to April 5, 2024. The Newcastle-Ottawa scale was used to assess the risk of bias. The included studies compared the incidence of postoperative complications between patients with different preoperative smoking cessation times and those with persistent preoperative smoking. A meta-analysis of postoperative complications and events such as pneumonia was performed in patients with lung cancer.</p><p><strong>Results: </strong>Fourteen studies met the inclusion criteria and included a total of 50,741 patients who had undergone pulmonary resection. The meta-analysis showed that preoperative smoking cessation of > 2 weeks and < 1 month did not reduce the incidence of postoperative complications (odds ratio [OR] 1.05; 95% confidence interval [CI] 0.76-1.44; P = 0.78) and pneumonia (OR 0.98; 95% CI 0.60-1.61; P = 0.95). Moreover, preoperative smoking cessation for > 1 month was effective in reducing the incidence of postoperative complications (OR 0.72; 95% CI 0.63-0.83; P < 0.01) as well as pneumonia (OR 0.80; 95% CI 0.49-1.33; P = 0.40).</p><p><strong>Conclusions: </strong>This meta-analysis suggests that preoperative smoking cessation for > 1 month is effective in reducing complications and pneumonia after pulmonary resection in patients with lung cancer, especially as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery become more common.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"293"},"PeriodicalIF":2.5,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survival outcomes of lymph node dissection in early-stage epithelial ovarian cancer: identifying suitable candidates. 早期上皮性卵巢癌淋巴结清扫术的生存效果:确定合适的人选。
IF 2.5 3区 医学 Q3 ONCOLOGY Pub Date : 2024-11-07 DOI: 10.1186/s12957-024-03571-7
Huan Wang, Shuanghui Wang, Pengyu Wang, Yimin Han

Objective: The study aimed to assess the effect of lymph node dissection on survival outcomes in patients presenting with early-stage epithelial ovarian cancer and to delineate patient characteristics that may indicate a greater benefit from pelvic lymph node dissection.

Methods: A retrospective analysis was performed on individuals diagnosed with clinical stage I-II epithelial ovarian cancer who received primary cytoreductive surgery at the Cancer Hospital Affiliated with Harbin Medical University from January 1, 2010, to January 1, 2018. The investigation encompassed an examination of demographic data, clinicopathological profiles, perioperative complications, and survival outcomes.

Results: A total of 315 patients diagnosed with ovarian cancer were incorporated into the study and were segregated into two distinct cohorts: 217 patients who underwent lymphadenectomy (Group A) and 98 patients who did not undergo the procedure (Group B). The disparities in progression-free survival and overall survival between the two cohorts did not attain statistical significance (p > 0.05). Upon conducting a subgroup analysis, it was discerned that patients characterized by clear cell carcinoma as the pathological subtype demonstrated a significantly extended progression-free survival post-lymphadenectomy (p = 0.02). Additionally, the operative duration for the patients in Group A was significantly protracted in comparison to Group B (146.15 ± 39.132 min vs. 133.49 ± 35.308 min, P = 0.043).

Conclusion: For patients with early-stage ovarian cancer, lymph node dissection does not significantly improve progression-free or overall survival rates. Our findings suggest that individuals with clear cell carcinoma pathology have a higher probability of benefiting in terms of survival following lymph node dissection.

研究目的该研究旨在评估淋巴结清扫术对早期上皮性卵巢癌患者生存预后的影响,并明确盆腔淋巴结清扫术可使患者获益更多的患者特征:我们对2010年1月1日至2018年1月1日期间在哈尔滨医科大学附属肿瘤医院接受初次细胞减灭术的临床I-II期上皮性卵巢癌患者进行了回顾性分析。调查内容包括人口统计学数据、临床病理学特征、围手术期并发症和生存结果:共有 315 名确诊为卵巢癌的患者被纳入研究,并被分为两个不同的队列:217名患者接受了淋巴腺切除术(A组),98名患者未接受该手术(B组)。两组患者的无进展生存期和总生存期差异未达到统计学意义(P > 0.05)。进行亚组分析后发现,病理亚型为透明细胞癌的患者在淋巴腺切除术后的无进展生存期明显延长(P = 0.02)。此外,与 B 组相比,A 组患者的手术时间明显延长(146.15±39.132 分钟 vs. 133.49±35.308 分钟,P = 0.043):结论:对于早期卵巢癌患者,淋巴结清扫术并不能显著提高无进展生存率或总生存率。我们的研究结果表明,病理为透明细胞癌的患者在淋巴结清扫术后获益的概率更高。
{"title":"Survival outcomes of lymph node dissection in early-stage epithelial ovarian cancer: identifying suitable candidates.","authors":"Huan Wang, Shuanghui Wang, Pengyu Wang, Yimin Han","doi":"10.1186/s12957-024-03571-7","DOIUrl":"10.1186/s12957-024-03571-7","url":null,"abstract":"<p><strong>Objective: </strong>The study aimed to assess the effect of lymph node dissection on survival outcomes in patients presenting with early-stage epithelial ovarian cancer and to delineate patient characteristics that may indicate a greater benefit from pelvic lymph node dissection.</p><p><strong>Methods: </strong>A retrospective analysis was performed on individuals diagnosed with clinical stage I-II epithelial ovarian cancer who received primary cytoreductive surgery at the Cancer Hospital Affiliated with Harbin Medical University from January 1, 2010, to January 1, 2018. The investigation encompassed an examination of demographic data, clinicopathological profiles, perioperative complications, and survival outcomes.</p><p><strong>Results: </strong>A total of 315 patients diagnosed with ovarian cancer were incorporated into the study and were segregated into two distinct cohorts: 217 patients who underwent lymphadenectomy (Group A) and 98 patients who did not undergo the procedure (Group B). The disparities in progression-free survival and overall survival between the two cohorts did not attain statistical significance (p > 0.05). Upon conducting a subgroup analysis, it was discerned that patients characterized by clear cell carcinoma as the pathological subtype demonstrated a significantly extended progression-free survival post-lymphadenectomy (p = 0.02). Additionally, the operative duration for the patients in Group A was significantly protracted in comparison to Group B (146.15 ± 39.132 min vs. 133.49 ± 35.308 min, P = 0.043).</p><p><strong>Conclusion: </strong>For patients with early-stage ovarian cancer, lymph node dissection does not significantly improve progression-free or overall survival rates. Our findings suggest that individuals with clear cell carcinoma pathology have a higher probability of benefiting in terms of survival following lymph node dissection.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"294"},"PeriodicalIF":2.5,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11542237/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of Surgical Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1